SEC Form 4 · accession 0001415889-15-003894
Cocrystal Pharma, Inc. · COCP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Curtis Dale
Officer — INTERIM CFO
Period of report
Nov 24, 2015
Accepted (ET)
Nov 25, 2015 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412486
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (Right to Buy)F2,F1 | $0.74 | Nov 24, 2015 | A | 100,000 | A | — | Nov 24, 2025 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The Securities vest in four equal annual increments with the first vesting date being one year from the Transaction Date, subject to continued employment and accelerated vesting under certain conditions.
- F2Not applicable.